Cargando…

Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study

BACKGROUND: There is limited, poorly characterized information about adverse events occurring during maintenance treatment of bipolar disorder. We aimed to determine adverse event rates during treatment with lithium, valproate, olanzapine, and quetiapine. METHODS AND FINDINGS: We conducted a propens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Joseph F., Marston, Louise, Walters, Kate, Geddes, John R., King, Michael, Osborn, David P. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970809/ https://www.ncbi.nlm.nih.gov/pubmed/27483368 http://dx.doi.org/10.1371/journal.pmed.1002058

Ejemplares similares

Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014()
por: Hayes, Joseph F., et al.
Publicado: (2017)

Nonlinear time-series approaches in characterizing mood stability and mood instability in bipolar disorder
por: Bonsall, M. B., et al.
Publicado: (2012)

Control charts for monitoring mood stability as a predictor of severe episodes in patients with bipolar disorder
por: Vazquez-Montes, Maria D. L. A., et al.
Publicado: (2018)

Mood stability versus mood instability in bipolar disorder: A possible role for emotional mental imagery
por: Holmes, Emily A., et al.
Publicado: (2011)

Mood dynamics in bipolar disorder
por: Moore, Paul J, et al.
Publicado: (2014)

Pharmacogenomics of Mood Stabilizers in the Treatment of Bipolar Disorder
por: Squassina, Alessio, et al.
Publicado: (2010)

Therapeutic monitoring of mood stabilizers in bipolar disorder
por: Falfel, D., et al.
Publicado: (2021)

Prescribing Trends in Bipolar Disorder: Cohort Study in the United Kingdom THIN Primary Care Database 1995–2009
por: Hayes, Joseph, et al.
Publicado: (2011)

Mood Stabilisers, but for Lithium, are not stabilizing Moods! Bipolar Disorders: Clinical conundrums 2
por: Reddy, M. S., et al.
Publicado: (2017)

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015)

Trajectories of adherence to mood stabilizers in patients with bipolar disorder
por: Bauer, M., et al.
Publicado: (2019)

RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
por: Pisanu, Claudia, et al.
Publicado: (2023)

Effectiveness of mood stabilizers in prophylactic treatment of bipolar disorder
por: Khattech, D., et al.
Publicado: (2023)

Antipsychotics and mood stabilizers on risk for hepatic failure in people with schizophrenia and bipolar disorder
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

A systematic review and meta‐analysis of premature mortality in bipolar affective disorder
por: Hayes, J. F., et al.
Publicado: (2015)

Is there an association between perceived social support and cardiovascular health behaviours in people with severe mental illnesses?
por: Burton, Alexandra, et al.
Publicado: (2020)

Stabilization Beyond Mood: Stabilizing Patients With Bipolar Disorder in the Various Phases of Life
por: Simonetti, Alessio, et al.
Publicado: (2020)

Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials
por: Kishi, Taro, et al.
Publicado: (2020)

Borderline Personality Disorder: Bipolarity, Mood Stabilizers and Atypical Antipsychotics in Treatment
por: Belli, Hasan, et al.
Publicado: (2012)

General pharmacokinetic/pharmacodynamic concepts of mood stabilizers in the treatment of bipolar disorder
por: Ware, Kenric, et al.
Publicado: (2016)

Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
por: Di Salvo, Gabriele, et al.
Publicado: (2020)

Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder
por: Qureshi, Mutahira M., et al.
Publicado: (2021)

Neuromolecular Etiology of Bipolar Disorder: Possible Therapeutic Targets of Mood Stabilizers
por: Lee, Jung Goo, et al.
Publicado: (2022)

Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder
por: Attianese, N., et al.
Publicado: (2023)

Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis
por: Severus, Emanuel, et al.
Publicado: (2014)

Tolerance to the Prophylactic Effects of Carbamazepine and Related Mood Stabilizers in the Treatment of Bipolar Disorders
por: Post, Robert M., et al.
Publicado: (2010)

Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder: Current Status of Knowledge
por: Rybakowski, Janusz K.
Publicado: (2013)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder
por: Yasui-Furukori, Norio, et al.
Publicado: (2020)

Decelerated epigenetic aging associated with mood stabilizers in the blood of patients with bipolar disorder
por: Okazaki, Satoshi, et al.
Publicado: (2020)

Prescribing of antipsychotics in UK primary care: a cohort study
por: Marston, Louise, et al.
Publicado: (2014)

Cushing's syndrome presenting as treatment-resistant bipolar affective disorder: A step in understanding endocrine etiology of mood disorders
por: Ummar, I. Syed, et al.
Publicado: (2015)

Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder
por: Pilhatsch, Maximilian, et al.
Publicado: (2018)

Report of three cases that received maintenance treatment with risperidone as a mood stabilizer
por: Fountoulakis, Konstantinos N, et al.
Publicado: (2004)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
por: Faurholt-Jepsen, Maria, et al.
Publicado: (2019)

Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
por: Karhapää, Hanna, et al.
Publicado: (2022)

The Uncharted Landscape of Rare Endocrine Immune-Related Adverse Events
por: Mytareli, Chrysoula, et al.
Publicado: (2023)

A systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder
por: Hui, T. P., et al.
Publicado: (2019)

White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder()
por: Yip, Sarah W., et al.
Publicado: (2013)

Mood‐Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome‐Wide Association Study
por: Ho, Ada Man‐Choi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m7odnjs0clu72pe7pjcce07fvb